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1726-4ReplyTo the Editor,
We appreciate Dr. Viroj Wiwanitkit's comments1 on our
article “Overview of Ebola virus disease in 2014”.2 As a
matter of fact, early diagnosis of Ebola virus disease (EVD) is
exceedingly difficult. Based on the CDC website, antigen-
capture enzyme-linked immunosorbent assay (ELISA) test-
ing, IgM ELISA, Polymerase chain reaction (PCR) and virus
isolation may currently be used as diagnostic tests for patients
with symptoms within a few days.3 However, false negative
results may occur. Several new molecular diagnostic
tools4e6are currently under investigation, but those tools
require further validation.7 Therefore, we believe that quar-
antine and symptomatic monitoring are very important for
outbreak prevention. In the USA, the risk classification of
Ebola virus spreading includes four grades, from no risk to
high risk. Only those patients who are at risk require active (or
direct active) monitoring.8 Our country is not an epidemic area
of EVD, and routine laboratory monitoring is not practical.
The governmental guidelines issued by CDC Taiwan, there-
fore, focus on monitoring travel history and constitutional
symptoms. Once suspected patients who met the criteria of
clinical and epidemiologic conditions, they will be quar-
antined for further laboratory screening tests. If screening tests
within a certain interval are negative, quarantine will be over.
For those from an epidemic area who are without symptoms,
self-monitoring for 21 days is recommended.9
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